Genetic determinants of blood gene expression and splicing and their contribution to molecular phenotypes and health outcomes
View ORCID ProfileAlex Tokolyi, View ORCID ProfileElodie Persyn, Artika P. Nath, View ORCID ProfileKatie L. Burnham, Jonathan Marten, Thomas Vanderstichele, Manuel Tardaguila, David Stacey, Ben Farr, Vivek Iyer, Xilin Jiang, Samuel A. Lambert, Guillaume Noell, Michael A. Quail, Diana Rajan, Scott C. Ritchie, Benjamin B. Sun, Scott A.J. Thurston, Yu Xu, Christopher D. Whelan, Heiko Runz, Slavé Petrovski, Daniel J. Gaffney, David J. Roberts, Emanuele Di Angelantonio, James E. Peters, Nicole Soranzo, John Danesh, Adam S. Butterworth, View ORCID ProfileMichael Inouye, View ORCID ProfileEmma E. Davenport, View ORCID ProfileDirk S. Paul
doi: https://doi.org/10.1101/2023.11.25.23299014
Alex Tokolyi
1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK
Elodie Persyn
2British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
3Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK
4Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Artika P. Nath
4Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
5Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia
Katie L. Burnham
1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK
Jonathan Marten
2British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Thomas Vanderstichele
1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK
Manuel Tardaguila
1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK
6Human Technopole, Fondazione Human Technopole, Milan, Italy
David Stacey
2British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
7Australian Centre for Precision Health, University of South Australia, Adelaide, SA, Australia
8South Australian Health and Medical Research Institute, Adelaide, SA, Australia
Ben Farr
1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK
Vivek Iyer
1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK
Xilin Jiang
2British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
3Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK
9Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
Samuel A. Lambert
2British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
3Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK
4Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
10Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK
Guillaume Noell
1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK
Michael A. Quail
1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK
Diana Rajan
1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK
Scott C. Ritchie
2British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
3Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK
4Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
5Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia
10Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK
11British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK
Benjamin B. Sun
12Translational Sciences, Research & Development, Biogen, Cambridge, MA, USA
Scott A.J. Thurston
1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK
Yu Xu
2British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
3Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK
4Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Christopher D. Whelan
13Neuroscience Data Science, Janssen Research & Development, Cambridge, MA, USA
Heiko Runz
12Translational Sciences, Research & Development, Biogen, Cambridge, MA, USA
Slavé Petrovski
14Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
15Department of Medicine, University of Melbourne, Austin Health, Melbourne, VIC, Australia
Daniel J. Gaffney
1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK
16Genomics, BioMarin Pharmaceutical Inc., Novato, CA, USA
David J. Roberts
17Radcliffe Department of Medicine, John Radcliffe Hospital, Oxford, UK
18Clinical Services, NHS Blood and Transplant, Oxford Centre, John Radcliffe Hospital, Oxford, UK
Emanuele Di Angelantonio
2British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
3Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK
6Human Technopole, Fondazione Human Technopole, Milan, Italy
10Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK
11British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK
19NIHR Blood and Transplant Research Unit in Donor Health and Behaviour, University of Cambridge, Cambridge, UK
James E. Peters
20Department of Immunology and Inflammation, Imperial College London, London, UK
Nicole Soranzo
1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK
6Human Technopole, Fondazione Human Technopole, Milan, Italy
John Danesh
1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK
2British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
3Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK
10Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK
11British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK
19NIHR Blood and Transplant Research Unit in Donor Health and Behaviour, University of Cambridge, Cambridge, UK
Adam S. Butterworth
2British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
3Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK
10Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK
11British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK
19NIHR Blood and Transplant Research Unit in Donor Health and Behaviour, University of Cambridge, Cambridge, UK
Michael Inouye
2British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
3Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK
4Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
5Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia
10Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK
11British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK
Emma E. Davenport
1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK
Dirk S. Paul
2British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
3Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK
14Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
Data Availability
The INTERVAL study data used in this paper are available to bona fide researchers from ceu-dataaccess{at}medschl.cam.ac.uk. The data access policy for the data is available at http://www.donorhealth-btru.nihr.ac.uk/project/bioresource. The newly generated RNA-sequencing data (n=4,732 INTERVAL participants) have been deposited at the European Genome-phenome Archive (EGA) under the accession number EGAD00001008015. The results from the genetic association, colocalization and mediation analyses are available at https://IntervalRNA.org.uk. All original code has been deposited at GitHub at https://github.com/INTERVAL-RNAseq/manuscript-scripts.
Posted November 27, 2023.
Genetic determinants of blood gene expression and splicing and their contribution to molecular phenotypes and health outcomes
Alex Tokolyi, Elodie Persyn, Artika P. Nath, Katie L. Burnham, Jonathan Marten, Thomas Vanderstichele, Manuel Tardaguila, David Stacey, Ben Farr, Vivek Iyer, Xilin Jiang, Samuel A. Lambert, Guillaume Noell, Michael A. Quail, Diana Rajan, Scott C. Ritchie, Benjamin B. Sun, Scott A.J. Thurston, Yu Xu, Christopher D. Whelan, Heiko Runz, Slavé Petrovski, Daniel J. Gaffney, David J. Roberts, Emanuele Di Angelantonio, James E. Peters, Nicole Soranzo, John Danesh, Adam S. Butterworth, Michael Inouye, Emma E. Davenport, Dirk S. Paul
medRxiv 2023.11.25.23299014; doi: https://doi.org/10.1101/2023.11.25.23299014
Genetic determinants of blood gene expression and splicing and their contribution to molecular phenotypes and health outcomes
Alex Tokolyi, Elodie Persyn, Artika P. Nath, Katie L. Burnham, Jonathan Marten, Thomas Vanderstichele, Manuel Tardaguila, David Stacey, Ben Farr, Vivek Iyer, Xilin Jiang, Samuel A. Lambert, Guillaume Noell, Michael A. Quail, Diana Rajan, Scott C. Ritchie, Benjamin B. Sun, Scott A.J. Thurston, Yu Xu, Christopher D. Whelan, Heiko Runz, Slavé Petrovski, Daniel J. Gaffney, David J. Roberts, Emanuele Di Angelantonio, James E. Peters, Nicole Soranzo, John Danesh, Adam S. Butterworth, Michael Inouye, Emma E. Davenport, Dirk S. Paul
medRxiv 2023.11.25.23299014; doi: https://doi.org/10.1101/2023.11.25.23299014
Subject Area
Subject Areas
- Addiction Medicine (430)
- Allergy and Immunology (754)
- Anesthesia (221)
- Cardiovascular Medicine (3287)
- Dermatology (277)
- Emergency Medicine (479)
- Epidemiology (13354)
- Forensic Medicine (19)
- Gastroenterology (898)
- Genetic and Genomic Medicine (5144)
- Geriatric Medicine (481)
- Health Economics (782)
- Health Informatics (3263)
- Health Policy (1140)
- Hematology (429)
- HIV/AIDS (1017)
- Medical Education (476)
- Medical Ethics (126)
- Nephrology (522)
- Neurology (4916)
- Nursing (262)
- Nutrition (725)
- Oncology (2518)
- Ophthalmology (723)
- Orthopedics (280)
- Otolaryngology (347)
- Pain Medicine (323)
- Palliative Medicine (90)
- Pathology (542)
- Pediatrics (1299)
- Primary Care Research (556)
- Public and Global Health (7492)
- Radiology and Imaging (1704)
- Respiratory Medicine (980)
- Rheumatology (479)
- Sports Medicine (424)
- Surgery (547)
- Toxicology (72)
- Transplantation (235)
- Urology (205)